TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 138 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $32,534,016 | -17.1% | 2,118,100 | +21.4% | 0.59% | -23.4% |
Q1 2023 | $39,229,307 | +48.9% | 1,744,300 | +39.2% | 0.77% | +52.8% |
Q4 2022 | $26,353,324 | -14.7% | 1,253,130 | 0.0% | 0.50% | -12.0% |
Q3 2022 | $30,877,000 | +65.0% | 1,253,130 | +62.3% | 0.57% | +69.0% |
Q2 2022 | $18,710,000 | +41.9% | 772,200 | +46.2% | 0.34% | +175.6% |
Q1 2021 | $13,187,000 | – | 528,100 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 1,028,875 | $25,351,000 | 8.34% |
GREAT POINT PARTNERS LLC | 966,108 | $23,805,000 | 5.73% |
Deep Track Capital, LP | 4,000,000 | $98,560,000 | 4.51% |
RA Capital Management | 4,922,941 | $121,301,000 | 2.59% |
ARMISTICE CAPITAL, LLC | 5,836,000 | $143,799,000 | 2.49% |
Kynam Capital Management, LP | 416,729 | $10,268,000 | 2.16% |
MPM BioImpact LLC | 276,460 | $6,812,000 | 1.61% |
HighVista Strategies LLC | 110,698 | $2,728,000 | 1.56% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 186,019 | $4,582,000 | 1.47% |
SECTORAL ASSET MANAGEMENT INC | 249,700 | $6,153,000 | 1.21% |